Influence of Race and Dietary Salt on the Antihypertensive Efficacy of an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Antagonist in Salt-Sensitive Hypertensives
- 1 May 1998
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 31 (5), 1088-1096
- https://doi.org/10.1161/01.hyp.31.5.1088
Abstract
Abstract —Dietary salt restriction is a recommended adjunct with antihypertensive therapy. There may be racial differences in blood pressure response to salt restriction while on antihypertensive therapy. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial (black, n=96; Hispanic, n=63; white, n=232). Participants were initially preselected for stage I to III hypertension and then further selected for salt sensitivity (≥5 mm Hg increase in diastolic blood pressure after 3 weeks of low salt [≤88 mmol/d Na + ] and high salt [>190 mmol/d Na + ] diet). We compared the antihypertensive effect of an angiotensin-converting enzyme inhibitor (enalapril 5 or 20 mg BID) or a calcium channel antagonist (isradipine 5 or 10 mg BID) during alternating periods of high and low salt intake. The main outcome measure was blood pressure change and absolute blood pressure level achieved with therapy. During the high salt diet (314.7±107.5 mmol/d urinary Na + ) there was greater downward change in blood pressure with both enalapril and isradipine compared with the low salt diet (90.1±50.8 mmol/d Na + ); however, the absolute blood pressure achieved in all races was consistently lower on a low salt diet for both agents. Black, white, and Hispanic isradipine-treated salt-sensitive hypertensives demonstrated a smaller difference between high and low salt diets (black, −3.6/−1.6 mm Hg; white, −6.2/−3.9 mm Hg; Hispanic, −8.1/−5.3 mm Hg) than did enalapril-treated patients (black, −9.0/−5.3 mm Hg; white, −11.8/−7.0 mm Hg; Hispanic, −11.1/−5.6 mm Hg). On the low salt diet, blacks, whites, and Hispanics had similar blood pressure control with enalapril and isradipine. On the high salt diet, blacks had better blood pressure control with isradipine than with enalapril, whereas there was no difference in the blood pressure control in whites and Hispanics treated with either drug. Dietary salt reduction helps reduce blood pressure in salt-sensitive hypertensive blacks, whites, and Hispanics treated with enalapril or isradipine. These data demonstrate that controlling for salt sensitivity diminishes race-related differences in antihypertensive activity.Keywords
This publication has 24 references indexed in Scilit:
- Salt sensitivity in blacks. Salt intake and natriuretic substances.Hypertension, 1988
- Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free intervalThe American Journal of Cardiology, 1988
- Multiple effects of calcium entry blockers on renal function in hypertension.Hypertension, 1987
- Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.JCI Insight, 1985
- Urinary electrolytes, body weight, and blood pressure. Pooled cross-sectional results among four groups of adolescent females.Hypertension, 1980
- Increased Sodium-Lithium Countertransport in Red Cells of Patients with Essential HypertensionNew England Journal of Medicine, 1980
- Laboratory Distinction between Essential and Secondary Hypertension by Measurement of Erythrocyte Cation FluxesNew England Journal of Medicine, 1980
- Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences.Hypertension, 1979
- Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects.Hypertension, 1979
- Racial differences in pressure, volume and renin interrelationships in essential hypertension.Hypertension, 1979